Article Per Year (5 Year)
p-Index From 2021 - 2026
2.255
P-Index
This Author published in this journals
All Journal journal of internal medicine INDONESIAN JOURNAL OF BIOMEDICAL SCIENCES MNJ (Malang Neurology Journal) The Indonesian Biomedical Journal Indonesian Journal of Cardiology Journal of the Indonesian Medical Association : Majalah Kedokteran Indonesia Heart Science Journal Narra J Proceedings Book of International Conference and Exhibition on The Indonesian Medical Education and Research Institute
Anwar Santoso
Faculty of Medicine Udayana University, Denpasar
Biochemistry, Genetics & Molecular Biology Education Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience Public Health

Published : 22 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 22 Documents
Search

 1   2   3 
Triglyceride Glucose Index as a Predictor of 30-Day Readmission and 6 Months Mortality After Hospitalization in Acute Decompensated Heart Failure Rezeki, Arindya; Widyantoro, Bambang; Rossimarina, Vienna; Dwiputra, Bambang; Danny, Siska Surinanda; Sukmawan, Renan; Santoso, Anwar
Jurnal Kardiologi Indonesia Vol 46 No 4 (2025): October - December, 2025
Publisher : The Indonesian Heart Association

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30701/ijc.2029

Abstract

In “Triglyceride Glucose Index as a Predictor of 30-Day Readmission and 6 Months Mortality After Hospitalization in Acute Decompensated Heart Failure” (Indonesian Journal of Cardiology, 44(2), 53-60. https://doi.org/10.30701/ijc.1380), there are an errors noted. An error has been found in the PDF version of this article. The DOI printed in the PDF is incorrect. The correct DOI is https://doi.org/10.30701/ijc.1380. The error occurs only in the PDF; the DOI listed in the article metadata is already correct. An error also occurred in the author’s name. We have corrected the author’s name from “Vienna Rossiamarina” to “Vienna Rossimarina.” There is also an error in the page numbering on the first page of the article. At the top, it says “57-64,” but we have changed it to the correct page numbers (53-60). The publisher apologizes for any inconvenience caused by this error.DOI of original article: https://doi.org/10.30701/ijc.1380
The Role of PCSK9 Inhibition and Small Interference RNA (siRNA) in The Management of Dyslipidaemia and ASCVD Santoso, Anwar; Dwiputra, Bambang
The Indonesian Biomedical Journal Vol 18, No 2 (2026)
Publisher : The Prodia Education and Research Institute (PERI)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18585/inabj.v18i2.4041

Abstract

Compelling evidence linking low-density lipoprotein cholesterol (LDL-C) reduction to decreased mortality has positioned LDL-C lowering as a central strategy in the prevention of atherosclerotic cardiovascular disease (ASCVD). Nonetheless, despite widespread statin use, an estimated 10–20% of individuals at high or very high cardiovascular risk fail to attain guideline-recommended LDL-C targets. This persistent treatment gap underscores the need for more potent and durable lipid-lowering strategies, particularly among patients with familial hypercholesterolemia (FH) and those with established ASCVD whose LDL-C levels remain inadequately controlled despite optimized combination therapy, including statins, ezetimibe, and proprotein convertase subtilisin–kexin type 9 (PCSK9) monoclonal antibodies. Inclisiran, a first-in-class small interfering RNA agent, addresses this unmet need by selectively inhibiting hepatic synthesis of PCSK9, thereby enhancing low-density lipoprotein receptor (LDLR) recycling and accelerating LDL-C clearance. Nevertheless, thus far, no cardiovascular outcome trial (CVOT) has been available. With a convenient twice-yearly dosing regimen, inclisiran consistently achieves LDL-C reductions exceeding 50% and demonstrates a favourable tolerability profile, offering an effective and patient-friendly advancement in dyslipidaemia management.KEYWORDS: dyslipidaemia, ASCVD, PCSK9 inhibition, siRNA, inclisiran 
Co-Authors AAG Budhitresna Adam, Erika Ambari, Ade Meidian Aria Kekalih Asrory, Virna Dwi Oktariana Badai Bhatara Tiksnadi Bambang Budi Siswanto Bambang Widyantoro Basuni Radi Bayushi Eka Putra Budi Rahmat Busro, Pribadi W. Christy, Kelly Danny, Siska Surinanda Desandri, Dwita Rian Dewa Gde Agung Budiyasa Dicky Armein Hanafy Dicky Fakhri Dwiputra, Bambang Dwiputra, Bambang Erwinanto, Erwinanto Gede Kambayana Gede Putu Arsana Harahap, Alida R. Harahap, Alida Rosita Harbanu H Mariyono Hermanto, Dony Yugo I Dewa Nyoman Wibawa I Gde Raka Widiana I Gede Ketut Sajinadiyasa I Gusti Ngurah Ketut Budiarsa I Ketut Suastika I Ketut Sujana I NYOMAN MANTIK ASTAWA Irawan Yusuf Katsukawa, Hajime Liastuti, Lies Dina Listyaningsih, Erlin Marita Kaniawati Michael Caesario Mukti, Aryo A.P. Nusanti, Synthia Oktarina, Virna Dwi Pintaningrum, Yusra Poh, Kian K. Pritazahra, Armalya Purba, Salomo Putra, Magma Purnawan R. A.T. Kuswardhani Renan Sukmawan Rezeki, Arindya Rif'ati, Lutfah Rossimaria, Vienna Rossimarina, Vienna Samsuridjal Djauzi Seskoati Prayitnaningsih Simbolon, Jessica Putri Natalia Siska Suridanda Danny Sunanto Ng Sunu Budhi Raharjo Syakib Bakri Syntia Nusanti Tambunan, Tresia Fransiska Ulianna Tambunan, Tresia FU. Teuku Heriansyah, Teuku Tianing - Triangto, Kevin Wicaksono, Sony Hilal Wienta Diarsvitri Wira Gotera Yoga Yuniadi ZAHRA, RITA